Equities analysts expect Prestige Consumer Healthcare Inc (NYSE:PBH) to post earnings per share (EPS) of $0.70 for the current quarter, according to Zacks. Four analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with estimates ranging from $0.69 to $0.72. Prestige Consumer Healthcare reported earnings per share of $0.62 in the same quarter last year, which suggests a positive year over year growth rate of 12.9%. The company is scheduled to issue its next earnings report on Thursday, May 9th.
According to Zacks, analysts expect that Prestige Consumer Healthcare will report full year earnings of $2.77 per share for the current year, with EPS estimates ranging from $2.75 to $2.78. For the next fiscal year, analysts anticipate that the firm will post earnings of $2.83 per share, with EPS estimates ranging from $2.80 to $2.85. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Prestige Consumer Healthcare.
Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.02. The firm had revenue of $241.40 million during the quarter, compared to analysts’ expectations of $241.40 million. Prestige Consumer Healthcare had a return on equity of 11.85% and a net margin of 6.44%. The company’s quarterly revenue was down 10.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 EPS.
Shares of NYSE PBH opened at $28.32 on Tuesday. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 10.98, a P/E/G ratio of 1.56 and a beta of 0.98. The company has a quick ratio of 1.34, a current ratio of 2.28 and a debt-to-equity ratio of 1.49. Prestige Consumer Healthcare has a fifty-two week low of $26.25 and a fifty-two week high of $41.76.
Institutional investors have recently bought and sold shares of the company. First Hawaiian Bank raised its holdings in shares of Prestige Consumer Healthcare by 218.4% during the 4th quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock worth $37,000 after buying an additional 830 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth $37,000. Captrust Financial Advisors grew its position in Prestige Consumer Healthcare by 23.8% during the 4th quarter. Captrust Financial Advisors now owns 2,228 shares of the company’s stock worth $69,000 after acquiring an additional 428 shares during the last quarter. First Quadrant L P CA bought a new stake in Prestige Consumer Healthcare during the 4th quarter worth $72,000. Finally, CWM LLC grew its position in Prestige Consumer Healthcare by 31,718.2% during the 4th quarter. CWM LLC now owns 3,500 shares of the company’s stock worth $108,000 after acquiring an additional 3,489 shares during the last quarter.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Recommended Story: Cost of Debt
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.